BCL2 and acute myeloid leukemia: p53-targeted genes include several BCL-2 family members (i.e., BAK, BAX, PUMA, and NOXA), which implicate marked disruption of apoptosis regulation in TP53-mutated cells, the basis for the well-known chemoresistance in this AML subset [105].